- Home
- Publications
- Publication Search
- Publication Details
Title
Hepta-Histidine Inhibits Tau Aggregation
Authors
Keywords
-
Journal
ACS Chemical Neuroscience
Volume 12, Issue 16, Pages 3015-3027
Publisher
American Chemical Society (ACS)
Online
2021-07-28
DOI
10.1021/acschemneuro.1c00164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology
- (2020) Hikari Tanaka et al. Nature Communications
- Impact of the Hereditary P301L Mutation on the Correlated Conformational Dynamics of Human Tau Protein Revealed by the Paramagnetic Relaxation Enhancement NMR Experiments
- (2020) Ryosuke Kawasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease
- (2019) Makoto Hashimoto et al. Journal of Parkinsons Disease
- Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all- d -enantiomeric peptides developed for the treatment of Alzheimer's disease
- (2018) Elena Schartmann et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation
- (2018) Teikichi Ikura et al. FEBS LETTERS
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
- (2017) Gordon K. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau
- (2016) S. J. Jackson et al. JOURNAL OF NEUROSCIENCE
- Identification of hepta-histidine as a candidate drug for Huntington’s disease by in silico-in vitro- in vivo-integrated screens of chemical libraries
- (2016) Tomomi Imamura et al. Scientific Reports
- The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons
- (2014) Christina R. Muratore et al. HUMAN MOLECULAR GENETICS
- Using chemical shift perturbation to characterise ligand binding
- (2013) Mike P. Williamson PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
- Peptidyl-prolyl isomerase activity of FK506 binding protein 12 prevents tau peptide from aggregating
- (2013) T. Ikura et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Polyglutamine neurodegeneration: expanded glutamines enhance native functions
- (2012) Harry T Orr CURRENT OPINION IN GENETICS & DEVELOPMENT
- Mutant huntingtin impairs Ku70-mediated DNA repair
- (2010) Yasushi Enokido et al. JOURNAL OF CELL BIOLOGY
- Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
- (2009) Tetsuaki Arai et al. ACTA NEUROPATHOLOGICA
- Transactive Response DNA-Binding Protein 43 Burden in Familial Alzheimer Disease and Down Syndrome
- (2009) Carol F. Lippa et al. ARCHIVES OF NEUROLOGY
- Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease
- (2008) Claudia Schwab et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies
- (2008) Kunihiro Uryu et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia
- (2008) Kurt A. Jellinger Neurodegenerative Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started